Clavulanic acid (CA) is an irreversible β-lactamase enzyme inhibitor with a weak
antibacterial activity produced by Streptomyces clavuligerus (S. clavuligerus). CA is typically …

β-Lactamase inhibitors have emerged as an effective alternative to reduce the effects of
resistance against β-lactam antibiotics. The Streptomyces genus is known for being an …

This work is the first attempt to apply aqueous two-phase mixed micellar systems (ATPMS) of
the nonionic surfactant Triton X-114 and the anionic one AOT to extract clavulanic acid (CA) …

Separation of azadirachtin and other limonoids from neem oil was carried out using solvent
induced precipitation method. Hexane was chosen as the solvent due to its low polarity that …

Clavulanic acid (CA) is an important pharmaceutical compound produced by batch
fermentation of Streptomyces clavuligerus. Since, CA is chemically unstable, its downstream …

The influence of four variables, specifically PEG molar mass (400, 1,000, and 8,000 g/mol),
concentrations of PEG and phosphate salts (15, 20, and 25% for both), and agitation …

In situ phenol pertraction with 1-octanol has been experimentally studied to improve the
production of the model component phenol by a recombinant strain of Pseudomonas putida …

Clavulanic acid is a drug obtained by Streptomyces sp. Fermentation and therapeutically
employed in association with β-lactamic antibiotics to avoid bacterial resistance. Its industrial …

Pseudomonas aeruginosa possesses beta-lactams resistance machinery by secretion of
extracellular beta-lactamase enzyme. The present study was begun with collection of eighty …

This paper describes a conceptual process design for the production of the model
component phenol by a recombinant strain of the micro-organism Pseudomonas putida S12 …